Literature DB >> 305493

Chronic fatal pneumocystosis in nude mice.

K Ueda, Y Goto, S Yamazaki, K Fujiwara.   

Abstract

A chronic pulmonary disease was encountered in nude mice of a barrier sustained colony, and Pneumocystis carinii was identified as the causative agent histopathologically as well as on impression smear preparations in the affected lungs. Fatal infection was seen only in old nude mice aged more than 6 months, while focal pulmonary lesions were developed without clinical signs in young adult nudes 2 to 3 months of age. The lesions produced in aged nude mice were characterized by propagation of mononuclear cells with the presence of foamy masses of P. carinii. Heterozygous littermates were much less susceptible to the infection but pneumocystic lesions could be produced readily by multiple treatment with immunosuppressants. The infection could be transmitted without immunosuppressant to non-infected nudes but not to heterozygous littermates after intranasal inoculation of affected tissue emulsion or by cage mating with severely affected nudes.

Entities:  

Mesh:

Year:  1977        PMID: 305493

Source DB:  PubMed          Journal:  Jpn J Exp Med        ISSN: 0021-5031


  9 in total

1.  Latent Pneumocystis carinii infection in commercial rat colonies: comparison of inductive immunosuppressants plus histopathology, PCR, and serology as detection methods.

Authors:  S H Weisbroth; J Geistfeld; S P Weisbroth; B Williams; S H Feldman; M J Linke; S Orr; M T Cushion
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

2.  Growth characteristics and pathogenesis of experimental Pneumocystis carinii pneumonia.

Authors:  P D Walzer; R D Powell; K Yoneda; M E Rutledge; J E Milder
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

3.  Experimental Pneumocystis carinii pneumonia in different strains of cortisonized mice.

Authors:  P D Walzer; R D Powell; K Yoneda
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

4.  Mouse model for Pneumocystis carinii pneumonia that uses natural transmission to initiate infection.

Authors:  M A Powles; D C McFadden; L A Pittarelli; D M Schmatz
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

5.  Serum antibody responses to Pneumocystis carinii among different strains of normal and athymic mice.

Authors:  P D Walzer; M E Rutledge
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

6.  Cellular and humoral immune responses of mice subclinically infected with Pneumocystis carinii.

Authors:  T Furuta; K Ueda; K Fujiwara; K Yamanouchi
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

7.  Comparison of corticosteroid- and L3T4+ antibody-immunosuppressed mouse models of Pneumocystis carinii pneumonia for evaluation of drugs and leukocytes.

Authors:  M S Bartlett; W L Current; A Orazi; N L Bauer; R S Neiman; S F Queener; J W Smith
Journal:  Clin Diagn Lab Immunol       Date:  1994-09

8.  Outbreaks of Pneumocystis carinii pneumonia in colonies of immunodeficient mice.

Authors:  P D Walzer; C K Kim; M J Linke; C L Pogue; M J Huerkamp; C E Chrisp; A V Lerro; S K Wixson; E Hall; L D Shultz
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

9.  Production of a monoclonal antibody with specificity for the pellicle of Pneumocystis carinii by hybridoma.

Authors:  Y Matsumoto; T Amagai; M Yamada; J Imanishi; Y Yoshida
Journal:  Parasitol Res       Date:  1987       Impact factor: 2.289

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.